Intuitive Surgical (ISRG) Stock Analysis & AI Equity Report

Medical - Equipment & Services USD Explore free reports

Intuitive Surgical (ISRG) overview

Intuitive Surgical (ISRG) stock analysis and AI equity research. For financial year 2025, Valuatum's model shows revenue of USD 10,065m and operating profit of USD 2,946m; the year-end share price was 566.36 USD and market capitalisation was USD 201,114m. Intuitive Surgical is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get Intuitive Surgical's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.

Key metrics & valuation multiples

Book valueUSD 17,824mFY 2025
Share price566.36 USDFY 2025 year end
RevenueUSD 10,065mFY 2025
Operating profitUSD 2,946mFY 2025
Net earningsUSD 2,856mFY 2025
Market capitalisationUSD 201,114mFY 2025 year end

About Intuitive Surgical

Intuitive Surgical develops robotic-assisted systems, instruments, accessories, digital tools, customer learning, and support services for minimally invasive care. Its da Vinci platforms support a range of surgical procedures, while the Ion system enables minimally invasive lung biopsies. The company’s products and services serve clinicians and care teams, and are used in healthcare settings involving patients, hospitals, healthcare systems, and payers.

Generate the Intuitive Surgical report

Intuitive Surgical is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.

Generate fresh report — €50.00 Delivered by email, usually within an hour

Sources & methodology

Financial figures are sourced from Valuatum's financial model for Intuitive Surgical and represent financial year 2025. See the methodology for the full Valuatum AI equity research framework.

Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.

Analyst reports on Intuitive Surgical

Each report here is this company's Valuatum report re-run with an analyst's own assumptions and published under their name. They are ordered by a score out of five: what other analysts felt the work added over the engine's default report.